ASCO Gynecologic Cancer | Conference

Molecular-Based Classification for Endometrial Cancer Could Help Predict Survival
June 23, 2016

Researchers were able to molecularly classify endometrial cancers with distinct survival differences using a new classification tool called ProMisE that uses clinically applicable methods.

Cisplatin/Paclitaxel Plus RT Offers Good Results in Advanced Cervical Cancer
June 22, 2016

A concurrent chemotherapy and radiotherapy regimen with cisplatin and paclitaxel yielded a good response rate and strong long-term survival outcomes in patients with locally advanced or recurrent cervical cancer.

T Cell Diversity in Tumor May Influence Ovarian Cancer Outcomes
June 17, 2016

In this video Dr. Odunsi discusses a new study that found that higher T-cell diversity in ovarian cancer is associated with poor overall survival.